Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

Program Overview

Bipolar disorder is a serious and chronic psychiatric disorder associated with substantial symptomatology, morbidity, and an increased risk of premature mortality, owing to both, a predominance of bipolar depression, as well as, numerous medical comorbidities. Two clinical experts discuss the diagnosis and treatment of bipolar depression, highlighting the role of psychiatric nursing professionals in these processes.

This activity was designed to improve the knowledge and competence of psychiatric advanced practice nurses with respect to the ready recognition and optimal treatment of adults with bipolar depression.

Credit Expired
0.75 CE Credit(s)
Expires: September 10, 2022

Target Audience

This activity is intended for psychiatric advanced practice nurses (APNs), nurse practitioners (NPs), clinical nurse specialists (CNS), and registered nurses (RNs) who are directly involved with diagnosing and managing pediatric patients with bipolar depression.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Apply established screening tools and diagnostic criteria to readily identify patients with bipolar depression
  • Employ current efficacy, safety, and tolerability data on effective treatments for patients with bipolar depression
  • Utilize effective strategies to improve outcomes in patients with bipolar depression


Activity Faculty


Sara Jones, PhD, RN, APRN, PMHNP-BC, FAAN, FAANP (Chair)

Associate Professor
University of Arkansas for Medical Sciences
College of Nursing
Little Rock, Arkansas

Manning_Sloan Headshot

James Sloan Manning, MD

Family Physician
Novant Health Salem Family Medicine
Winston-Salem, North Carolina

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

Supporter Statement

Provider Statement

Disclosure of Financial Relationships


Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources